ISRCTN22292536Completed未知
Treatment of wheezy infants with bronchodilators (comparison of inhaled ipratropium bromide versus inhaled salbutamol)
Department of Health (UK)0 sites0 target enrollmentStarted: September 12, 2003Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Children aged 3 to 18 months with persistent or recurrent wheezing and atopic tendencies
Exclusion Criteria
- •Not provided at time of registration
Investigators
Similar Trials
Withdrawn
Phase 4
Bronchodilators for wheeze in young children presenting to primary care: a randomised, placebo-controlled, multicentre, parallel group trial.respiratory tract infectionswheeze1004743810024970NL-OMON49680niversitair Medisch Centrum Utrecht150
Active, not recruiting
Phase 1
Bronchodilators for wheeze in young childreWheezing in infants and young children (6-24 months old)EUCTR2020-000313-33-BEMC Utrecht300
Active, not recruiting
Phase 1
Bronchodilators for wheeze in young childreWheezing in infants and young children (6-24 months old)EUCTR2020-000313-33-NLMC Utrecht300
Active, not recruiting
Unknown
Evaluating the clinical and cost effectiveness of breathing support treatment types in infants under 12 months of age with acute bronchiolitisRespiratoryBronchiolitisISRCTN52937119Imperial College London1,508
Withdrawn
Phase 4
Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group TrialWheezingNCT04584034UMC Utrecht